Journal
ANAESTHESIA AND INTENSIVE CARE MEDICINE
Volume 19, Issue 9, Pages 513-516Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.mpaic.2018.06.010
Keywords
Antiemetic drugs; emetic drugs; nausea; postoperative nausea and vomiting; vomiting
Categories
Ask authors/readers for more resources
Nausea and vomiting are both very unpleasant experiences. The physiology is poorly understood; however, understanding what we do know is key to tailoring a preventative or therapeutic antiemetic regime. There are two key sites in the central nervous system implicated in the organization of the vomiting reflex: the vomiting centre and the chemoreceptor trigger zone. There are five key neurotransmitters involved in afferent feedback to these areas. These are histamine (H-1 receptors), dopamine (D-2), serotonin (5-HT3), acetyl choline (muscarinic) and neurokinin (substance P). Postoperative nausea and vomiting will occur in around one-third of elective patients who have no prophylaxis. This can result in many detrimental effects including patient dissatisfaction, unplanned admission and prolonged recovery. It is therefore essential that clinicians understand how they can prevent and treat nausea and vomiting using either a single agent or a combination of antiemetics to target relevant receptors. Commonly used drugs include antihistamines, dopamine antagonists, serotonin antagonists and steroids. More novel agents are being developed such as aprepitant, a neurokinin receptor antagonist, palonosetron, a 5HT(3) receptor antagonist and nabilone, a synthetic cannabinoid.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available